NCT03030638View on ClinicalTrials.gov

Drug Utilization Study for Olodaterol

CompletedOBSERVATIONAL
Enrollment

27,606

Participants

Timeline

Start Date

February 8, 2017

Primary Completion Date

March 31, 2018

Study Completion Date

March 31, 2018

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

Olodaterol

Drug

DRUG

Indacaterol

Drug

Trial Locations (3)

Unknown

Aarhus Universitetshospital Skejby, Aarhus

IMS Health Information solutions, Courbevoie

Pharmo Institute, Utrecht

Sponsors
All Listed Sponsors
collaborator

RTI health solutions, US

UNKNOWN

lead

Boehringer Ingelheim

INDUSTRY

NCT03030638 - Drug Utilization Study for Olodaterol | Biotech Hunter | Biotech Hunter